Marina Darenskaya*, Liubov Kolesnikova and Sergei Kolesnikov Pages 1618 - 1627 ( 10 )
The spread of a new strain of coronavirus, SARS-CoV-2, a pandemic, poses a serious health problem for all humanity. Compared with the previous outbreaks of coronavirus infection in 2002 and 2012, COVID-19 infection has high rates of lethality, contagiousness, and comorbidity. The effective methods of prevention and treatment are extremely limited. Oxidative stress is actively involved in the mechanisms of initiation and maintenance of violations of homeostatic reactions in respiratory viral infections. It is important to stop systemic inflammation aimed at "extinguishing" the cytokine "storm", caused by the production of reactive oxygen species. Antioxidant defense medications, such as vitamin C, N-acetylcysteine, melatonin, quercetin, glutathione, astaxanthin, polyphenols, fat-soluble vitamins, and polyunsaturated fatty acids have proven well in experimental and clinical studies of influenza, pneumonia, and other respiratory disorders. The use of medications with antioxidant activity could be justified and most probably would increase the effectiveness of the fight against new coronavirus.
Antioxidants, coronaviruses, COVID-19, oxidative stress, pathogenesis, SARS-CoV-2.
Department of Pathophysiology, Scientific Centre for Family Health and Human Reproduction Problems, Irkutsk, Department of Pathophysiology, Scientific Centre for Family Health and Human Reproduction Problems, Irkutsk, Department of Pathophysiology, Scientific Centre for Family Health and Human Reproduction Problems, Irkutsk